ATYR Long Call Strategy

ATYR (aTyr Pharma, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

ATYR (aTyr Pharma, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $38.8M, a beta of 0.66 versus the broader market, a 52-week range of 0.395-7.29, average daily share volume of 1.4M, a public-listing history dating back to 2015, approximately 56 full-time employees. These structural characteristics shape how ATYR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.66 indicates ATYR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on ATYR?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current ATYR snapshot

As of May 15, 2026, spot at $0.49, ATM IV 22.70%, IV rank 0.34%, expected move 6.51%. The long call on ATYR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on ATYR specifically: ATYR IV at 22.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a ATYR long call, with a market-implied 1-standard-deviation move of approximately 6.51% (roughly $0.03 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ATYR expiries trade a higher absolute premium for lower per-day decay. Position sizing on ATYR should anchor to the underlying notional of $0.49 per share and to the trader's directional view on ATYR stock.

ATYR long call setup

The ATYR long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ATYR near $0.49, the first option leg uses a $0.49 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ATYR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ATYR shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$0.49N/A

ATYR long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

ATYR long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on ATYR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on ATYR

Long calls on ATYR express a bullish thesis with defined risk; traders use them ahead of ATYR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

ATYR thesis for this long call

The market-implied 1-standard-deviation range for ATYR extends from approximately $0.46 on the downside to $0.52 on the upside. A ATYR long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ATYR IV rank near 0.34% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ATYR at 22.70%. As a Healthcare name, ATYR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ATYR-specific events.

ATYR long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ATYR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ATYR alongside the broader basket even when ATYR-specific fundamentals are unchanged. Long-premium structures like a long call on ATYR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ATYR chain quotes before placing a trade.

Frequently asked questions

What is a long call on ATYR?
A long call on ATYR is the long call strategy applied to ATYR (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ATYR stock trading near $0.49, the strikes shown on this page are snapped to the nearest listed ATYR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ATYR long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ATYR long call priced from the end-of-day chain at a 30-day expiry (ATM IV 22.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ATYR long call?
The breakeven for the ATYR long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ATYR market-implied 1-standard-deviation expected move is approximately 6.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on ATYR?
Long calls on ATYR express a bullish thesis with defined risk; traders use them ahead of ATYR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current ATYR implied volatility affect this long call?
ATYR ATM IV is at 22.70% with IV rank near 0.34%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related ATYR analysis